Mankind Pharma Q1 Results
- BSE: 543904
- NSE: MANKIND
- ISIN: INE634S01028
- Sector: Biotechnology & Drugs
BSE
2,072.90
9.00 (0.44%)
9.00 (0.44%)Volume5.46 K
Updated: Wed 18 Feb, 2026 | 14:23:44
NSE
2,066.503.60 (0.17%)
3.60 (0.17%)Volume1.58 L
Updated: Wed 18 Feb, 2026 | 14:08:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Mankind Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2,942.26 | 2,566.74 | 14.63% | 2,298.98 | 27.98% |
| Depreciation/ Amortization | 218.68 | 215.56 | 1.45% | 102.69 | 112.95% |
| Operating Income | 628.09 | 440.77 | 42.50% | 568.87 | 10.41% |
| Net Income | 438.32 | 420.77 | 4.17% | 536.49 | -18.30% |
| Other Operating Expenses Total | 886.58 | 782.33 | 13.33% | 757.16 | 17.09% |
| Net Income Before Taxes | 540.49 | 502.06 | 7.65% | 661.34 | -18.27% |
| Total Revenue | 3,570.35 | 3,007.51 | 18.71% | 2,867.85 | 24.50% |
| Selling/ General/ Admin Expenses Total | 783.41 | 702.45 | 11.53% | 629.70 | 24.41% |
| Diluted Normalized EPS | 10.60 | 10.08 | 5.21% | 13.26 | -20.03% |